C R Fumaz

Summary

Affiliation: Hospital Universitari Germans Trias i Pujol
Country: Spain

Publications

  1. ncbi Assessment of changes in adherence and quality of life after the simplification of antiretroviral treatment
    Carmina R Fumaz
    IAPAC Mon 9:145, 165. 2003
  2. ncbi Influence of the type of pegylated interferon on the onset of depressive and neuropsychiatric symptoms in HIV-HCV coinfected patients
    C R Fumaz
    Universitat Autonoma de Barcelona, Barcelona, Spain
    AIDS Care 19:138-45. 2007
  3. ncbi Long-term neuropsychiatric disorders on efavirenz-based approaches: quality of life, psychologic issues, and adherence
    Carmina R Fumaz
    Lluita contra la SIDA Foundation, HIV Unit Germans Trias i Pujol Hospital, Autonomous University of Barcelona, Barcelona, Spain
    J Acquir Immune Defic Syndr 38:560-5. 2005
  4. ncbi Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimens
    Carmina R Fumaz
    HIV Unit, Fundació Lluita SIDA and IrsiCaixa Retrovirology Laboratory, Germans Trias i Pujol University Hospital, Badalona, Catalonia, Spain
    J Acquir Immune Defic Syndr 29:244-53. 2002
  5. ncbi Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up
    E Negredo
    Fundació Lluita contra la Sida, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
    Antivir Ther 4:23-8. 1999
  6. ncbi Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy
    A Tuldrá
    HIV Unit, Fundació Lluita SIDA and IrsiCaixa Retrovirology Laboratory, Germans Trias i Pujol University Hospital, Badalona, Spain
    J Acquir Immune Defic Syndr 25:221-8. 2000
  7. ncbi Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with hiv-associated lipodystrophy: 1-year prospective follow-up of a multicenter, randomized, controlled study
    L Ruiz
    IrsiCaixa Foundation, Retrovirology Laboratory and HIV Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
    J Acquir Immune Defic Syndr 27:229-36. 2001
  8. ncbi Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients
    Lidia Ruiz
    Fundació IrsiCaixa and HIV Clinical Unit, Hospital Universitari Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona, Spain
    AIDS 21:169-78. 2007
  9. ncbi Psychological impact of structured treatment interruptions in patients with prolonged undetectable HIV-1 viral loads
    A Tuldrá
    Fundació Lluita SIDA HIV Clinical Unit and IrsiCaixa Retrovirology Laboratory, Catalonia, Spain
    AIDS 15:1904-6. 2001
  10. ncbi Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs
    C R Fumaz
    Lluita contra la SIDA Foundation, Barcelona, Spain
    AIDS Care 20:796-805. 2008

Detail Information

Publications21

  1. ncbi Assessment of changes in adherence and quality of life after the simplification of antiretroviral treatment
    Carmina R Fumaz
    IAPAC Mon 9:145, 165. 2003
  2. ncbi Influence of the type of pegylated interferon on the onset of depressive and neuropsychiatric symptoms in HIV-HCV coinfected patients
    C R Fumaz
    Universitat Autonoma de Barcelona, Barcelona, Spain
    AIDS Care 19:138-45. 2007
    ....
  3. ncbi Long-term neuropsychiatric disorders on efavirenz-based approaches: quality of life, psychologic issues, and adherence
    Carmina R Fumaz
    Lluita contra la SIDA Foundation, HIV Unit Germans Trias i Pujol Hospital, Autonomous University of Barcelona, Barcelona, Spain
    J Acquir Immune Defic Syndr 38:560-5. 2005
    ..Efavirenz has been associated with neuropsychiatric disorders, although little is known about its long-term toxicity...
  4. ncbi Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimens
    Carmina R Fumaz
    HIV Unit, Fundació Lluita SIDA and IrsiCaixa Retrovirology Laboratory, Germans Trias i Pujol University Hospital, Badalona, Catalonia, Spain
    J Acquir Immune Defic Syndr 29:244-53. 2002
    ....
  5. ncbi Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up
    E Negredo
    Fundació Lluita contra la Sida, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
    Antivir Ther 4:23-8. 1999
    ..Maintenance of viral suppression was equivalent in both treatment groups. Additional data with longer follow-up are needed to confirm these results...
  6. ncbi Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy
    A Tuldrá
    HIV Unit, Fundació Lluita SIDA and IrsiCaixa Retrovirology Laboratory, Germans Trias i Pujol University Hospital, Badalona, Spain
    J Acquir Immune Defic Syndr 25:221-8. 2000
    ..Interventions to ensure a high level of adherence during a relatively long-term period of therapy are necessary...
  7. ncbi Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with hiv-associated lipodystrophy: 1-year prospective follow-up of a multicenter, randomized, controlled study
    L Ruiz
    IrsiCaixa Foundation, Retrovirology Laboratory and HIV Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
    J Acquir Immune Defic Syndr 27:229-36. 2001
    ..Small nonrandomized studies have suggested a beneficial role of PI-sparing regimens on lipodystrophy...
  8. ncbi Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients
    Lidia Ruiz
    Fundació IrsiCaixa and HIV Clinical Unit, Hospital Universitari Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona, Spain
    AIDS 21:169-78. 2007
    ..We evaluated the safety of CD4 cell count and plasma HIV-1 RNA (pVL)-guided treatment interruptions (GTI) and determined predictors of duration of treatment interruption...
  9. ncbi Psychological impact of structured treatment interruptions in patients with prolonged undetectable HIV-1 viral loads
    A Tuldrá
    Fundació Lluita SIDA HIV Clinical Unit and IrsiCaixa Retrovirology Laboratory, Catalonia, Spain
    AIDS 15:1904-6. 2001
    ..However, a close follow-up of patients during interruption periods is advisable to avoid difficulties reported at treatment resumption presenting a risk to patients' health...
  10. ncbi Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs
    C R Fumaz
    Lluita contra la SIDA Foundation, Barcelona, Spain
    AIDS Care 20:796-805. 2008
    ..Adherence was more related to beliefs about health and illness than to the characteristics of medication or level of knowledge about treatment. Care adherence interventions should include assessment of health beliefs...
  11. ncbi Neuropsychiatric symptoms associated with efavirenz: prevalence, correlates, and management. A neurobehavioral review
    Jose A Muñoz-Moreno
    Lluita Contra la SIDA Foundation Germans Trias i Pujol University Hospital, Badalona, Barcelona, Spain
    AIDS Rev 11:103-9. 2009
    ..Different recommendations on the assessment of efavirenz-related adverse events are also provided...
  12. ncbi Reconstructive treatment for antiretroviral-associated facial lipoatrophy: a prospective study comparing autologous fat and synthetic substances
    Eugenia Negredo
    HIV Unit, Fundació de la Lluita contra la SIDA, Germans Trias i Pujol University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain
    AIDS Patient Care STDS 20:829-37. 2006
    ..Similar results were observed for all degrees of severity and between genders. Polyacrylamide gel provided the longest lasting benefits...
  13. ncbi Variability in non-nucleoside reverse transcriptase and protease inhibitors concentrations among HIV-infected adults in routine clinical practice
    Jose Molto
    Lluita contra la SIDA Foundation, Germans Trias i Pujol Hospital, Badalona, Barcelona, Spain
    Br J Clin Pharmacol 63:715-21. 2007
    ....
  14. ncbi Interruptions of antiretroviral therapy in human immunodeficiency virus infection: are they detrimental to neurocognitive functioning?
    Jose A Muñoz-Moreno
    Lluita contra la SIDA Foundation, Germans Trias i Pujol University Hospital, Badalona, Barcelona, Catalonia, Spain
    J Neurovirol 16:208-18. 2010
    ..Additionally, neurocognitive functioning was observed to be more impaired in the same individuals. Further studies should examine the potential negative effects of antiretroviral therapy interruptions on neurocognitive functioning...
  15. ncbi [Recommendations from GESIDA/SEFH/PNS to improve adherence to antiviral treatment (2004)]
    Hernando Knobel
    Servicio Medicina Interna, Hospital del Mar, Barcelona, Spain
    Enferm Infecc Microbiol Clin 23:221-31. 2005
    ..The choice of therapy, only one aspect of the multidimensional problem of adherence, must be a careful and individualized decision; however, simpler regimens with regard to the number of pills and daily dose are desirable...
  16. ncbi Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial
    Javier Martinez-Picado
    IrsiCaixa Foundation, Hospital Germans Trias i Pujol, Carretera de Canyet s n, 08916 Badalona, Spain
    Ann Intern Med 139:81-9. 2003
    ..Mathematical modeling has suggested that alternating antiretroviral regimens while patients' viral load remains suppressed would minimize HIV resistance mutations...
  17. ncbi Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression
    Eugenia Negredo
    Fundació Lluita contra la Sida, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain
    Clin Infect Dis 34:504-10. 2002
    ..Quality of life significantly improved for groups A and B. In patients receiving effective PI-based therapy, the replacement of the PI with either nevirapine or efavirenz is safe and virologically effective...
  18. ncbi Assessing self-reported adherence to HIV therapy by questionnaire: the SERAD (Self-Reported Adherence) Study
    Jose A Muñoz-Moreno
    Lluita contra la SIDA Foundation, Badalona, Barcelona, Catalonia, Spain
    AIDS Res Hum Retroviruses 23:1166-75. 2007
    ....
  19. ncbi Low levels of adherence to antiretroviral therapy in HIV-1-infected women with menstrual disorders
    Carmina R Fumaz
    Lluita contra la SIDA Foundation, Germans Trias i Pujol University Hospital, Badalona, Barcelona, Spain
    AIDS Patient Care STDS 23:463-8. 2009
    ..The subjective attribution of these irregularities to antiretrovirals seems to affect medication intake, possibly favoring negative clinical consequences...
  20. ncbi Variability in non-nucleoside reverse transcriptase and protease inhibitor concentrations among HIV-infected adults in routine clinical practice
    Jose Molto
    Lluita contra la SIDA Foundation, Badalona, Barcelona, Spain
    Br J Clin Pharmacol 62:560-6. 2006
    ....
  21. ncbi Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients
    Jose A Muñoz-Moreno
    Lluita contra la SIDA Foundation, Germans Trias i Pujol University Hospital, Badalona, Barcelona, Catalonia, Spain
    AIDS Res Hum Retroviruses 24:1301-7. 2008
    ..We found differences in neurocognitive functioning in relation to nadir CD4 count in HIV-infected patients. Attention should be given to this value in the management of neurocognitive protection in HIV infection...